PF-03814735

DB13059InvestigationalSmall molecule

PF-03814735 has been used in trials studying the treatment of Solid Tumors.

Mechanism: Pharmacologically active on Aurora kinase B and Aurora kinase A
Curator reviewed
Formula / weight: C₂₃H₂₅F₃N₆O₂ · 474.488 g/mol (avg)
Code names: PF 03814735 · PF-3814735

Resolves to

Compound

Structure

InChIKeyRYYNGWLOYLRZLK-RBUKOAKNSA-NSMILESCC(=O)NCC(=O)N1[C@H]2CC[C@@H]1C1=C2C=CC(NC2=NC=C(C(NC3CCC3)=N2)C(F)(F)F)=C1

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-03814735, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.